Literature DB >> 14729607

Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations.

Naomoto Harada1, Hiroko Oshima, Masahiro Katoh, Yositaka Tamai, Masanobu Oshima, Makoto M Taketo.   

Abstract

We have established previously a mouse strain containing a mutant beta-catenin allele of which exon 3 was sandwiched by loxP sequences [Catnb(lox(ex3))]. In this mouse strain, a Wnt-activating beta-catenin mutation alone is insufficient for hepatocarcinogenesis, but additional mutations or epigenetic changes may be required. Here we report that hepatocellular carcinoma develops at the 100% incidence in mice with simultaneous mutations in the beta-catenin and H-ras genes that are introduced by adenovirus-mediated Cre expression. Although H-ras mutation alone rapidly causes large cell dysplasia in the hepatocytes, these cells show no autonomous growth within 1 week after infection of the Cre-adenovirus. However, simultaneous induction of an additional mutation in the beta-catenin gene causes a clonal expansion of such dysplastic cells, followed by nodular formation and development of hepatocellular carcinoma. These results indicate that beta-catenin mutations play a critical role in hepatocarcinogenesis in cooperation with another oncogene and that these mice provide a convenient model to investigate early steps of hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729607     DOI: 10.1158/0008-5472.can-03-2123

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  72 in total

Review 1.  Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

Authors:  Kari Nichole Nejak-Bowen; Satdarshan P S Monga
Journal:  Semin Cancer Biol       Date:  2010-12-21       Impact factor: 15.707

2.  Effect of mutant β-catenin on liver growth homeostasis and hepatocarcinogenesis in transgenic mice.

Authors:  Timothy J Stein; Adam Jochem; Katie E Holmes; Eric P Sandgren
Journal:  Liver Int       Date:  2011-01-19       Impact factor: 5.828

3.  β-catenin mutation is correlated with a favorable prognosis in patients with hepatocellular carcinoma.

Authors:  Zheng Wang; Yuan-Yuan Sheng; Xiao-Mei Gao; Chao-Qun Wang; Xiang-Yu Wang; X U Lu; Jin-Wang Wei; Kai-Li Zhang; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  Mol Clin Oncol       Date:  2015-05-15

4.  Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis.

Authors:  Wantae Kim; Sanjoy Kumar Khan; Jelena Gvozdenovic-Jeremic; Youngeun Kim; Jason Dahlman; Hanjun Kim; Ogyi Park; Tohru Ishitani; Eek-Hoon Jho; Bin Gao; Yingzi Yang
Journal:  J Clin Invest       Date:  2016-11-21       Impact factor: 14.808

Review 5.  Immunobiology of hepatocarcinogenesis: Ways to go or almost there?

Authors:  Pavan Patel; Steven E Schutzer; Nikolaos Pyrsopoulos
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

Review 6.  Wnt signaling in liver cancer.

Authors:  Yutaka Takigawa; Anthony M C Brown
Journal:  Curr Drug Targets       Date:  2008-11       Impact factor: 3.465

7.  Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment.

Authors:  Kenneth E Hung; Marco A Maricevich; Larissa Georgeon Richard; Wei Y Chen; Michael P Richardson; Alexandra Kunin; Roderick T Bronson; Umar Mahmood; Raju Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

Review 8.  Mouse models in liver cancer research: a review of current literature.

Authors:  Martijn W H Leenders; Maarten W Nijkamp; Inne H M Borel Rinkes
Journal:  World J Gastroenterol       Date:  2008-12-07       Impact factor: 5.742

9.  Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis.

Authors:  Chuan-Rui Xu; Susie Lee; Coral Ho; Prashant Bommi; Shi-Ang Huang; Siu Tim Cheung; Goberdhan P Dimri; Xin Chen
Journal:  Mol Cancer Res       Date:  2009-11-24       Impact factor: 5.852

10.  Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo.

Authors:  Michael Buchert; Dimitris Athineos; Helen E Abud; Zoe D Burke; Maree C Faux; Michael S Samuel; Andrew G Jarnicki; Catherine E Winbanks; Ian P Newton; Valerie S Meniel; Hiromu Suzuki; Steven A Stacker; Inke S Näthke; David Tosh; Joerg Huelsken; Alan R Clarke; Joan K Heath; Owen J Sansom; Matthias Ernst
Journal:  PLoS Genet       Date:  2010-01-15       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.